Evidence map›Paper›PMID 25934174›Full record

ArticleBMC cancer2015

Clusterin transcript variants expression in thyroid tumor: a potential marker of malignancy?

Paolo Fuzio, Anna Napoli, Anna Ciampolillo, Serafina Lattarulo, Angela Pezzolla, Nicoletta Nuzziello, Sabino Liuni, Francesco Giorgino, Eugenio Maiorano, Elda Perlino

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. mRNA Isoforms and Variants in Health and Disease.International journal of molecular sciences · 2025
    Review
  4. Investigation of the Anticarcinogenic Effects ofAnti-cancer agents in medicinal chemistry · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Expression and Clinical Pathological Significance of miR-200a in Concurrent Cholangiocarcinoma Associated with Hepatolithiasis.Medical science monitor : international medical journal of experimental and clinical research · 2015
    Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Paolo FuzioInstitute of Biomedical Technologies, National Research Council (CNR), Via G. Amendola, 122/D, 70126, Bari, Italy. paolo.fuzio@ba.itb.cnr.it.
Anna NapoliDepartment of Emergency and Organ Transplantation, Section of Pathological Anatomy, University of Bari Aldo Moro, 70124, Bari, Italy. anna.napoli@uniba.it.
Anna CiampolilloDepartment of Emergency and Organ Transplantation, Section of Endocrinology, University of Bari Aldo Moro, 70124, Bari, Italy. anna.ciampolillo@uniba.it.
Serafina LattaruloDepartment of Emergency and Organ Transplantation, Section of Endocrinology, University of Bari Aldo Moro, 70124, Bari, Italy. s.lattarulo@virgilio.it.
Angela PezzollaDepartment of Emergency and Organ Transplantation, Section of Endocrinology, University of Bari Aldo Moro, 70124, Bari, Italy. apezzolla@chirges.uniba.it.
Nicoletta NuzzielloInstitute of Biomedical Technologies, National Research Council (CNR), Via G. Amendola, 122/D, 70126, Bari, Italy. nicoletta.nuzziello@gmail.com.
Sabino LiuniInstitute of Biomedical Technologies, National Research Council (CNR), Via G. Amendola, 122/D, 70126, Bari, Italy. sabino.liuni@ba.itb.cnr.it.
Francesco GiorginoDepartment of Emergency and Organ Transplantation, Section of Endocrinology, University of Bari Aldo Moro, 70124, Bari, Italy. francesco.giorgino@uniba.it.
Eugenio MaioranoDepartment of Emergency and Organ Transplantation, Section of Pathological Anatomy, University of Bari Aldo Moro, 70124, Bari, Italy. eugenio.maiorano@uniba.it.
Elda PerlinoInstitute of Biomedical Technologies, National Research Council (CNR), Via G. Amendola, 122/D, 70126, Bari, Italy. elda.perlino@ba.itb.cnr.it.
University of Bari Aldo Moro · ITInstitute of Biomedical Technologies · ITNational Research Council · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundClusterin (CLU) is a ubiquitous multifunctional factor involved in neoplastic transformation. The CLU transcript variants and protein forms play a crucial role in balancing cells proliferation and death.

methodsWe investigated the regulation of CLU transcript variants expression in an in vivo model system consisting of both neoplastic tissues and fine needle aspiration biopsy (FNAB) samples isolated from patients undergoing thyroidectomy.

resultsThe immunohistochemical analyses showed an overall CLU up-regulation in papillary carcinoma. A specific CLU2 transcript variant increase was registered using qPCR in papillary carcinomas while CLU1 decreased. In addition, the analysis of CLU transcripts expression level showed an increase of the CLU2 transcript in the TIR 3 patients with histologically confirmed thyroid cancer.

conclusionsOur results suggest the existence of a specific alteration of CLU2:CLU1 ratio towards CLU2, thus providing the first circumstantial evidence for the potential use of CLU transcript variants as effective biomarkers for a more accurate assessment of the so called "indeterminate" thyroid nodules.

Indexed as

AdultAgedBiomarkers, TumorCarcinoma, PapillaryClusterinFemaleHumansMaleMiddle AgedProtein IsoformsRNA, MessengerThyroid GlandThyroid NeoplasmsBiomarkers, TumorCLU protein, humanClusterinProtein IsoformsRNA, Messenger

Identifiers

PMID25934174
PMCPMC4422431
OpenAlexW1983333828

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.